Australia markets closed

Triterras, Inc. (TRIRF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0373+0.0122 (+48.61%)
At close: 03:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 2.85M
Enterprise value -26.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.05
Price/book (mrq)0.02
Enterprise value/revenue -0.44
Enterprise value/EBITDA 2.32

Trading information

Stock price history

Beta (5Y monthly) -0.10
52-week change 3-92.69%
S&P500 52-week change 316.55%
52-week high 30.6800
52-week low 30.0001
50-day moving average 30.0318
200-day moving average 30.1049

Share statistics

Avg vol (3-month) 312.97k
Avg vol (10-day) 326.43k
Shares outstanding 576.52M
Implied shares outstanding 676.52M
Float 824.44M
% held by insiders 168.03%
% held by institutions 10.03%
Shares short (13 Jan 2022) 42.14M
Short ratio (13 Jan 2022) 44.12
Short % of float (13 Jan 2022) 49.99%
Short % of shares outstanding (13 Jan 2022) 42.63%
Shares short (prior month 14 Dec 2021) 42.45M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 27 Feb 2022
Most-recent quarter (mrq)30 Aug 2022

Profitability

Profit margin -25.72%
Operating margin (ttm)-77.48%

Management effectiveness

Return on assets (ttm)-11.12%
Return on equity (ttm)-11.87%

Income statement

Revenue (ttm)60.21M
Revenue per share (ttm)0.79
Quarterly revenue growth (yoy)15.40%
Gross profit (ttm)35.51M
EBITDA -28.83M
Net income avi to common (ttm)-15.48M
Diluted EPS (ttm)-0.1900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.93M
Total cash per share (mrq)0.44
Total debt (mrq)4.56M
Total debt/equity (mrq)3.71%
Current ratio (mrq)4.50
Book value per share (mrq)1.60

Cash flow statement

Operating cash flow (ttm)-49.25M
Levered free cash flow (ttm)-60.38M